Khan Najat
Recursion Pharmaceuticals, Inc. · CEO and President
Khan Najat is listed in filings as CEO and President at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX). The current snapshot covers public activity from Feb 5, 2025 to Jun 5, 2026. Reported amounts are shown as $84.5K to $94.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $95k28.3k shares | SellMar 9, 2026 | $3.35 | $3.01 | |
| $549k124.4k shares | SellDec 22, 2025 | $4.41 | $3.01 | |
| $202k36.6k shares | SellAug 18, 2025 | $5.52 | $3.01 |